Effect of Formula on Infant Behavior

March 28, 2017 updated by: Abbott Nutrition

Effect of Formula Supplemented With Oligosaccharides on Infant Behavior

This is a prospective, multi-center, single-arm study to evaluate the symptoms of formula intolerance in healthy term infants.

Study Overview

Study Type

Interventional

Enrollment (Actual)

69

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35235
        • Alabama Clinical Therapeutics, LLC
      • Dothan, Alabama, United States, 36305
        • Southeastern Pediatric Associates
    • Arizona
      • Tucson, Arizona, United States, 85712
        • Watching Over Mothers and Babies
    • Connecticut
      • Norwich, Connecticut, United States, 06360
        • Norwich Pediatric Group, PC
    • Florida
      • Orlando, Florida, United States, 32825
        • Florida Institute for Clinical Research, LLC
      • Saint Petersburg, Florida, United States, 33710
        • SCORE Physician Alliance, LLC
    • Nebraska
      • Lincoln, Nebraska, United States, 68510
        • Women's Clinic of Lincoln, PC
    • Ohio
      • Cleveland, Ohio, United States, 44124
        • Institute of Clinical Research, LLC
      • Grove City, Ohio, United States, 43123
        • Aventiv Research
    • South Carolina
      • Charleston, South Carolina, United States, 29414
        • Coastal Pediatric Research
    • Texas
      • Longview, Texas, United States, 75605
        • DCOL Center for Clinical Research
      • San Antonio, Texas, United States, 78229
        • Southwest Children's Research Associates, P.A.
    • Utah
      • Layton, Utah, United States, 84041
        • Tanner Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 week to 1 month (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Subject is in good health as determined from subject's medical history by parent report
  • Subject is a singleton full-term birth with a gestational age of 37 - 42 weeks
  • Subject's birth weight was ≥ 2490 g (~5 lbs. 8 oz.)
  • Subject is between 7 and 42 days of age
  • Infant was identified by parents as very fussy or extremely fussy in the baseline tolerance evaluation
  • Infant is exclusively formula-fed at time of study entry
  • Parent(s) confirm their intention not to administer vitamin or mineral supplements, solid foods or juices to their infant from enrollment through the duration of the study
  • Subject's parent(s) has voluntarily signed and dated an informed consent form (ICF) prior to any participation in the study

Exclusion Criteria:

  • An adverse maternal, fetal or subject medical history that has potential for effects on tolerance, growth, and/or development
  • Subject is taking and plans to continue medications, home remedies, herbal preparations or rehydration fluids that might affect gastrointestinal (GI) tolerance
  • Subject participates in another study that has not been approved as a concomitant study
  • Subject has been fed any formula containing human milk oligosaccharides prior to study enrollment
  • Subject has been treated with oral antibiotics within 7 days prior to study enrollment
  • Mother intends to use a combination of breast and formula feeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Infant Formula supplemented with Oligosaccharides
Ready to feed infant formula ; Feed ad libitum.
sole source nutrition

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fussiness
Time Frame: Change from baseline (3 days prior to SD1) to within one day of initiation of study feeding (SD1)
Parent Questionnaires
Change from baseline (3 days prior to SD1) to within one day of initiation of study feeding (SD1)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fussiness
Time Frame: Baseline to SDAY 29
Parent Questionnaires
Baseline to SDAY 29
Hours of daily crying
Time Frame: Baseline to SDAY 29
Parent Questionnaires
Baseline to SDAY 29
Gastrointestinal Tolerance
Time Frame: Baseline to SDAY 29
Parent Questionnaires
Baseline to SDAY 29
Stool Pattern
Time Frame: Baseline to SDAY 29
Parent Questionnaire
Baseline to SDAY 29

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2016

Primary Completion (Actual)

October 1, 2016

Study Completion (Actual)

October 1, 2016

Study Registration Dates

First Submitted

April 13, 2016

First Submitted That Met QC Criteria

April 18, 2016

First Posted (Estimate)

April 21, 2016

Study Record Updates

Last Update Posted (Actual)

March 30, 2017

Last Update Submitted That Met QC Criteria

March 28, 2017

Last Verified

March 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • AL19

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gastrointestinal Tolerance

Clinical Trials on Infant Formula supplemented with Oligosaccharides

3
Subscribe